KBC Group NV lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 16.9% during the 4th quarter, Holdings Channel reports. The firm owned 245,111 shares of the company’s stock after selling 49,723 shares during the period. KBC Group NV’s holdings in Henry Schein were worth $17,129,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Thrivent Financial For Lutherans grew its holdings in shares of Henry Schein by 3.8% during the second quarter. Thrivent Financial For Lutherans now owns 3,000 shares of the company’s stock worth $549,000 after purchasing an additional 110 shares during the last quarter. Trust Co. of Vermont lifted its stake in shares of Henry Schein by 56.7% during the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after acquiring an additional 616 shares during the period. FTB Advisors Inc. lifted its stake in shares of Henry Schein by 100.0% during the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after acquiring an additional 742 shares during the period. Janney Montgomery Scott LLC lifted its stake in shares of Henry Schein by 31.3% during the third quarter. Janney Montgomery Scott LLC now owns 3,146 shares of the company’s stock valued at $258,000 after acquiring an additional 750 shares during the period. Finally, Lee Financial Co lifted its stake in shares of Henry Schein by 100.0% during the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after acquiring an additional 878 shares during the period. Institutional investors own 91.15% of the company’s stock.

In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total value of $410,124.96. Following the transaction, the director now owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.19% of the company’s stock.

Henry Schein, Inc. (HSIC) opened at $72.18 on Tuesday. Henry Schein, Inc. has a one year low of $65.28 and a one year high of $93.50. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $11,261.48, a PE ratio of 20.13, a price-to-earnings-growth ratio of 1.84 and a beta of 1.00.

HSIC has been the topic of several research reports. Robert W. Baird set a $95.00 price target on Henry Schein and gave the company a “buy” rating in a research note on Thursday, October 19th. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, November 13th. Stifel Nicolaus cut their price target on Henry Schein from $89.00 to $77.00 and set a “hold” rating on the stock in a research note on Tuesday, November 7th. Craig Hallum raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Finally, Evercore ISI initiated coverage on Henry Schein in a research note on Thursday, January 4th. They set an “outperform” rating and a $81.00 price target on the stock. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $84.23.

TRADEMARK VIOLATION WARNING: This report was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://theolympiareport.com/2018/02/13/henry-schein-inc-hsic-shares-sold-by-kbc-group-nv.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.